KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Liabilities and Shareholders Equity (2016 - 2026)

Medtronic's Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $91.5 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 1.68% to $91.5 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $365.5 billion, a 1.6% increase, with the full-year FY2025 number at $91.7 billion, up 1.89% from a year prior.
  • Liabilities and Shareholders Equity hit $91.5 billion in Q1 2026 for Medtronic, roughly flat from $91.3 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for MDT hit a ceiling of $94.1 billion in Q1 2023 and a floor of $89.7 billion in Q3 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $91.1 billion across 5 years, with a median of $90.9 billion in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 5.62% in 2022 and later rose 2.54% in 2023.
  • Tracing MDT's Liabilities and Shareholders Equity over 5 years: stood at $93.2 billion in 2022, then decreased by 3.38% to $90.1 billion in 2023, then dropped by 0.05% to $90.0 billion in 2024, then rose by 1.45% to $91.3 billion in 2025, then rose by 0.15% to $91.5 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for MDT at $91.5 billion in Q1 2026, $91.3 billion in Q4 2025, and $91.0 billion in Q3 2025.